Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.87 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.87 |
| ▸ | ACHE | P22303 | 3/20 | 0.75 |
| ▸ | BCHE | P06276 | 1/20 | 0.75 |
| ▸ | MAOB | P27338 | 2/20 | 0.68 |
| ▸ | MAOA | P21397 | 1/20 | 0.68 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.63 |
| ▸ | SIRT2 | Q8IXJ6 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16414740 | 1.00 | MEN1 (0.87) | MEN1KMT2AACHEBCHEMAOB | |
| SCHEMBL10070987 | 0.92 | ACHE (0.88) | MEN1KMT2AACHEBCHEMAOB | |
| SCHEMBL4434094 | 0.92 | ACHE (0.88) | MEN1KMT2AACHEBCHEMAOB | |
| SCHEMBL31634290 | 0.92 | ACHE (0.88) | MEN1KMT2AACHEBCHEMAOB | |
| N-Isoferuloyl Serotonin SCHEMBL803830 | 0.90 | PTGS2 (0.79) | MEN1KMT2AACHEBCHEMAOB | |
| SCHEMBL4427822 | 0.88 | PTGS2 (0.80) | MEN1KMT2AACHEBCHEMAOB | |
| SCHEMBL28015276 | 0.88 | PTGS2 (0.80) | MEN1KMT2AACHEBCHEMAOB | |
| SCHEMBL10071695 | 0.85 | MEN1 (0.72) | MEN1KMT2AACHEBCHEMAOB | |
| SCHEMBL798186 | 0.83 | MAOB (0.79) | MEN1KMT2AACHEBCHEMAOB | |
| SCHEMBL30753637 | 0.83 | MAOB (0.79) | MEN1KMT2AACHEBCHEMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150031740-A1 | COSMETIC COMPOSITION FOR STIMULATING THE CELLULAR ANTI-AGING FUNCTIONS OF THE SKIN | UNIVERSITE PAUL SABATIER TOULOUSE III (FR) | 2015-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150031740-A1 | COSMETIC COMPOSITION FOR STIMULATING THE CELLULAR ANTI-AGING FUNCTIONS OF THE SKIN | H1-0, C1R, H1-3 | MEN1 3291/4885KMT2A 3404/4885ACHE 1443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.